Physician profile
Ted Kim
NPI 1174303713
$908.01
in general payments reported to CMS, 2019-2025
13 companies · $908 in 2025
The $908 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.02 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $237.21 | 2025 | Jakafi, Monjuvi, Zynyz |
| Astrazeneca Pharmaceuticals LP | $182.40 | 2025 | Calquence |
| Abbvie INC. | $155.25 | 2025 | |
| Neurocrine Biosciences, INC. | $64.50 | 2025 | |
| Caris Mpi, INC. | $55.61 | 2025 | Mi Cancer Seek |
| Spectrum Pharmaceuticals INC. | $43.14 | 2025 | Rolvedon |
| Bayer Healthcare Pharmaceuticals INC. | $31.82 | 2025 | |
| Deciphera Pharmaceuticals INC. | $24.23 | 2025 | Qinlock, Romvimza |
| Glaxosmithkline, LLC. | $23.87 | 2025 | Blenrep |
| Dendreon Pharmaceuticals LLC | $23.46 | 2025 | Provenge |
| E.R. Squibb & Sons, L.L.C. | $23.21 | 2025 | Opdivo |
| Jazz Pharmaceuticals INC. | $23.09 | 2025 | |
| Helsinn Therapeutics (U.S.), INC. | $20.22 | 2025 | Akynzeo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.